CASP1 and metabolic dysfunction-associated steatohepatitis: In a murine model of NASH induced by a high-fat, high-cholesterol diet (HFHCD), the deficiency of caspase-1 has demonstrated efficacy in averting liver inflammation, fibrosis, and hepatic cell pyroptosis (Koh et al., 2021).